NEXT_CLINICAL_RESEARCH_OR - Accounts
NEXT_CLINICAL_RESEARCH_OR - Accounts
Company Registration No. 09418105 (England and Wales)
UNAUDITED ABBREVIATED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2015
CONTENTS
Page
Abbreviated balance sheet
1
Notes to the abbreviated accounts
2
ABBREVIATED BALANCE SHEET
AS AT
31 DECEMBER 2015
- 1 -
2015
Notes
£
£
Current assets
Debtors
Cash at bank and in hand
Creditors: amounts falling due within one year
(47,833 )
Total assets less current liabilities
(38,210 )
Capital and reserves
Called up share capital
2
Profit and loss account
(38,212 )
Shareholders' funds
(38,210 )
Directors' responsibilities:
-
-
Approved by the Board and authorised for issue on 13 December 2016
Director
Company Registration No. 09418105
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE PERIOD ENDED 31 DECEMBER 2015
- 2 -
1
Accounting policies
1.1
Accounting convention
1.2
Compliance with accounting standards
The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).
1.3
Turnover
1.4
Deferred taxation
Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.
1.5
Foreign currency translation
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to profit and loss account.
2
Share capital
2015
£
Allotted, called up and fully paid